China Biologic Products, Inc. (CBPO) - Financial and Strategic SWOT Analysis Review

Apr, 2016   |   25  Pages   |   GlobalData   |   Format : PDF

Summary

China Biologic Products, Inc. (CBP) is a plasma biopharmaceutical company that develops treatment products. The company manufactures, develops, and markets biologic products for the prevention and treatment of various diseases. Its plasma products include human albumin, human tetanus immunoglobulin, human rabies immunoglobulin, human immunoglobulin for intravenous injection, human hepatitis B immunoglobulin, thymopolypeptides injection, human immunoglobulin, and human coagulation factor VIII. CBP's other product includes placenta polypeptide. The company provides services including plasma collection, research and development, production, and commercialization of biopharmaceutical products. It offers products to hospitals and other healthcare facilities in China. CBP is headquartered in Chaoyang, China.

China Biologic Products, Inc. Key Recent Developments

Feb 25, 2016: China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2015
Nov 03, 2015: China Biologic Reports Financial Results for the Third Quarter of 2015
Sep 02, 2015: China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials
Aug 05, 2015: China Biologic Reports Financial Results for the Second Quarter of 2015
May 06, 2015: China Biologic Reports Financial Results for the First Quarter of 2015

This comprehensive SWOT profile of China Biologic Products, Inc. provides you an in-depth strategic analysis of the com

Table of Contents

Section 1 - About the Company

China Biologic Products, Inc. - Key Information
China Biologic Products, Inc. - Overview
China Biologic Products, Inc. - Key Employees
China Biologic Products, Inc. - Key Employee Biographies
China Biologic Products, Inc. - Key Operational Heads
China Biologic Products, Inc. - Major Products and Services
China Biologic Products, Inc. - History
China Biologic Products, Inc. - Company Statement
China Biologic Products, Inc. - Locations And Subsidiaries
China Biologic Products, Inc. - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

China Biologic Products, Inc. - Business Description
China Biologic Products, Inc. - Corporate Strategy
China Biologic Products, Inc. - SWOT Analysis
SWOT Analysis - Overview
China Biologic Products, Inc. - Strengths
China Biologic Products, Inc. - Weaknesses
China Biologic Products, Inc. - Opportunities
China Biologic Products, Inc. - Threats
China Biologic Products, Inc. - Key Competitors

Section 3 - Company Financial Performance Charts

China Biologic Products, Inc. - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company

List of Tables

China Biologic Products, Inc., Key Information
China Biologic Products, Inc., Key Ratios
China Biologic Products, Inc., Share Data
China Biologic Products, Inc., Major Products and Services
China Biologic Products, Inc., History
China Biologic Products, Inc., Key Employees
China Biologic Products, Inc., Key Employee Biographies
China Biologic Products, Inc., Key Operational Heads
China Biologic Products, Inc., Other Locations
China Biologic Products, Inc., Subsidiaries
China Biologic Products, Inc., Key Manufacturing facilities
China Biologic Products, Inc., Key Competitors
China Biologic Products, Inc., SWOT Analysis
China Biologic Products, Inc., Ratios based on current share price
China Biologic Products, Inc., Annual Ratios
China Biologic Products, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

China Biologic Products, Inc., Performance Chart
China Biologic Products, Inc., Ratio Charts

China Petrochemicals Report
The China Petrochemicals Report has been researched at source, and features BMI Research's market assessment and independent forecasts for key petrochemicals sub-sectors. The report also analyses the impact of regulatory changes, recent developments and the background macroeconomic outlook and featu
China Oil and Gas Report
BMI View: China's long-term crude oil and liquids output will remain on a firm downtrend as low oil prices slowdown exploration and render certain high-cost mature and unconventional plays uneconomic. Outlook is more positive for natural gas, as the government seeks to increase the share of ga
China Pharmaceuticals and Healthcare Report
BMI View: China will become a leading medical research hub within the Asia Pacific region. This will be largely led by multinational pharmaceutical firms as they seek to tap the large talent pool within the country and develop treatments 'in China, for China'. The local industry, while stil
China Telecommunications Report
BMI View: Operator strategies will continue to chime with the government's directive to drive uptake of wireline broadband and machine-to-machine (M2M) connections. However, this means that even as subscription numbers rise, the prices of basic services will be compressed and operators will derive p
Global and China Lithium Carbonate Industry Report, 2016-2020
Driven by a surge in sales volume of new energy vehicles in China, the upstream material- lithium carbonate was in short supply in the fourth quarter of 2015 with soaring prices. Global lithium carbonate output increased by 12.3% year on year to 202,800 tons in 2015 and is expected to arrive at 244,

Select a Licence type

Custom Research

We are known to provide exact requirements. Try our CUSTOM RESEARCH option and get the exact search result you are searching for.

Contact Us

Postal Address:
808, Real Tech Park, 8th Floor, Sector - 30A, Vashi, Navi Mumbai - 400703 , INDIA .
Telephone: +91 22 27810772, 27810773
Email: info@marketreportsonchina.com
Fax Number: +91 22 27812707

Follow Us On: